Panmure Gordon Increases Shire PLC Price Target to GBX 4,626 (SHP)
Stock analysts at Panmure Gordon upped their target price on shares of Shire PLC (LON:SHP) from GBX 3,800 ($64.51) to GBX 4,626 ($78.53) in a report issued on Friday. The firm currently has a “buy” rating on the stock. Panmure Gordon’s price target suggests a potential upside of 23.76% from the stock’s previous close.
Shares of Shire PLC (LON:SHP) traded up 19.90% during mid-day trading on Friday, hitting GBX 4482.00. 10,002,509 shares of the company’s stock traded hands. Shire PLC has a 52-week low of GBX 1978.0001 and a 52-week high of GBX 4248.7998. The stock has a 50-day moving average of GBX 3451.12 and a 200-day moving average of GBX 3128.58. The company’s market cap is £26.188 billion.
SHP has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Shire PLC in a research note on Tuesday. They now have a GBX 3,500 ($59.41) price target on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Shire PLC from GBX 3,920 ($66.54) to GBX 4,350 ($73.84) in a research note on Tuesday, June 10th. They now have a “buy” rating on the stock. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Shire PLC in a research note on Monday, June 2nd. They now have a GBX 3,400 ($57.72) price target on the stock. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of GBX 2,971.66 ($50.44).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.